Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis

被引:35
作者
Kain, Vasundhara [1 ]
Kumar, Sandeep [1 ]
Sitasawad, Sandhya L. [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
来源
CARDIOVASCULAR DIABETOLOGY | 2011年 / 10卷
关键词
Azelnidipine; Apoptosis; Ca2+ homeostasis; diabetic cardiomyopathy; mitochondria; oxidative stress; SARCOPLASMIC-RETICULUM CA2+-ATPASE; NADPH OXIDASE; VENTRICULAR MYOCYTES; CELL-DEATH; CHANNEL BLOCKER; HEART-FAILURE; CARDIOMYOPATHY; CA2+; METALLOTHIONEIN; OVEREXPRESSION;
D O I
10.1186/1475-2840-10-97
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Numerous evidences suggest that diabetic heart is characterized by compromised ventricular contraction and prolonged relaxation attributable to multiple causative factors including calcium accumulation, oxidative stress and apoptosis. Therapeutic interventions to prevent calcium accumulation and oxidative stress could be therefore helpful in improving the cardiac function under diabetic condition. Methods: This study was designed to examine the effect of long-acting calcium channel blocker (CCB), Azelnidipine (AZL) on contractile dysfunction, intracellular calcium (Ca2+) cycling proteins, stress-activated signaling molecules and apoptosis on cardiomyocytes in diabetes. Adult male Wistar rats were made diabetic by a single intraperitoneal (IP) injection of streptozotocin (STZ). Contractile functions were traced from live diabetic rats to isolated individual cardiomyocytes including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR90), maximal velocity of shortening/relengthening (+/- dL/dt) and intracellular Ca2+ fluorescence. Results: Diabetic heart showed significantly depressed PS, +/- dL/dt, prolonged TPS, TR90 and intracellular Ca2+ clearing and showed an elevated resting intracellular Ca2+. AZL itself exhibited little effect on myocyte mechanics but it significantly alleviated STZ-induced myocyte contractile dysfunction. Diabetes increased the levels of superoxide, enhanced expression of the cardiac damage markers like troponin I, p67(phox) NADPH oxidase subunit, restored the levels of the mitochondrial superoxide dismutase (Mn-SOD), calcium regulatory proteins RyR2 and SERCA2a, and suppressed the levels of the anti-apoptotic Bcl-2 protein. All of these STZ-induced alterations were reconciled by AZL treatment. Conclusion: Collectively, the data suggest beneficial effect of AZL in diabetic cardiomyopathy via altering intracellular Ca2+ handling proteins and preventing apoptosis by its antioxidant property.
引用
收藏
页数:12
相关论文
共 50 条
[41]   Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats [J].
Shao, Chun-Hong ;
Rozanski, George J. ;
Patel, Kaushik P. ;
Bidasee, Keshore R. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (01) :234-246
[42]   Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy [J].
Shen, X ;
Zheng, SR ;
Metreveli, NS ;
Epstein, PN .
DIABETES, 2006, 55 (03) :798-805
[43]   Diminished expression of sarcoplasmic reticulum Ca2+-ATPase and ryanodine sensitive Ca2+ channel mRNA in streptozotocin-induced diabetic rat heart [J].
Teshima, Y ;
Takahashi, N ;
Saikawa, T ;
Hara, M ;
Yasunaga, S ;
Hidaka, S ;
Sakata, T .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (04) :655-664
[44]   Overexpression of the sarcoplasmic reticulum Ca2+-ATPase improves myocardial contractility in diabetic cardiomyopathy [J].
Trost, SU ;
Belke, DD ;
Bluhm, WF ;
Meyer, M ;
Swanson, E ;
Dillmann, WH .
DIABETES, 2002, 51 (04) :1166-1171
[45]   Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: Reversal with endothelin antagonism [J].
Verma, S ;
Maitland, A ;
Weisel, RD ;
Li, SH ;
Fedak, PWM ;
Pomroy, NC ;
Mickle, DAG ;
Li, RK ;
Ko, L ;
Rao, V .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (06) :1120-1124
[46]   Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4 [J].
Wendt, MC ;
Daiber, A ;
Kleschyov, AL ;
Mülsch, A ;
Sydow, K ;
Schulz, E ;
Chen, K ;
Keaney, JF ;
Lassègue, B ;
Walter, U ;
Griendling, KK ;
Münzel, T .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (03) :381-391
[47]   Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes:: Role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme [J].
Wold, LE ;
Ceylan-Isik, AF ;
Fang, CX ;
Yang, XP ;
Li, SY ;
Sreejayan, N ;
Privratsky, JR ;
Ren, J .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (08) :1419-1429
[48]   Role of reactive oxygen species and NAD(P)H oxidase in α1-adrenoceptor signaling in adult rat cardiac myocytes [J].
Xiao, L ;
Pimentel, DR ;
Wang, J ;
Singh, K ;
Colucci, WS ;
Sawyer, DB .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 282 (04) :C926-C934
[49]   Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production [J].
Ye, G ;
Metreveli, NS ;
Ren, J ;
Epstein, PN .
DIABETES, 2003, 52 (03) :777-783
[50]   Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury [J].
Zhao, KS ;
Zhao, GM ;
Wu, DL ;
Soong, Y ;
Birk, AV ;
Schiller, PW ;
Szeto, HH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) :34682-34690